Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias
ENLACES RÁPIDOS

CUMBRE MONDIAL
SOBRE POLÍTICAS y
ACCESO A TRATAMIENTO

ÚNASE A NOSOTROS EN LÍNEA    10‑11 JULIO 2025

Cumbre mundial de la FMH sobre políticas y acceso a tratamiento

También disponible en: English Français

ORGANIZADOR:
Federación Mundial de Hemofilia

La cuarta edición de la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento (GPAS por su sigla en inglés) tendrá lugar del 10 al 11 de julio de 2025. Únase a sus colegas para:

  • Compartir estrategias a fin de preservar e impulsar la atención de los trastornos de la coagulación en un mundo en rápida evolución.
  • Promover el diálogo y el intercambio de conocimientos entre organizaciones nacionales miembros (ONM), proveedores de atención médica, y gobiernos nacionales, a fin de proporcionar una mejor atención.

Las presentaciones y charlas durante la cumbre virtual de dos días de duración se centrarán en incrementar el acceso al diagnóstico, la atención y el tratamiento para personas que viven con trastornos de la coagulación. La conferencia contará con ponentes y participantes de organizaciones aliadas locales e internacionales, representantes de gobiernos nacionales, profesionales de la salud, líderes de ONM de la FMH, y defensores de la comunidad de trastornos de la coagulación.

La Cumbre mundial de la FMH sobre políticas y acceso a tratamiento (GPAS por su sigla en inglés) constituye una oportunidad única a fin de documentar, debatir e intercambiar conocimientos sobre estrategias para incrementar el acceso equitativo a la atención y el tratamiento para la comunidad mundial de trastornos de la coagulación. ¡Esperamos conectarnos con ustedes virtualmente en julio próximo!

PROGRAMA

Este evento virtual de dos días de duración ofrecerá sesiones plenarias y educativas, y sesiones relámpago con casos de cabildeo, todas centradas en temas relacionados con el impulso a la atención y el acceso al tratamiento alrededor del mundo.

El horario de todas las sesiones es el Horario de Verano del Este (EDT).

Calendar

09:00 – 09:30

OPENING PLENARY

The Opening Plenary will highlight main WFH strategies to advance health equity in bleeding disorders care globally. WFH leadership will outline the program’s objectives and highlight key themes, including the importance of equitable access to diagnosis, treatment, and care for people with bleeding disorders, regardless of their bleeding disorder, gender, age or where they live. The plenary sets the stage for two days of collaboration, learning, and advocacy.

Chair

Alain Baumann, CEO, World Federation of Hemophilia, Montreal, Canada

Opening remarks – Advancing health equity

Cesar Garrido, President, World Federation of Hemophilia, Caracas, Venezuela

Keynote address

Deusdedit Mubangizi, Director, Health Products Policy and Standards Department, Access to Medicines and Health Products Division, World Health Organization, Geneva, Switzerland


09:30 – 10:45

EDUCATIONAL SESSION

Navigating the evolving treatment landscape for bleeding disorders

This session will explore the rapidly changing therapeutic landscape for bleeding disorders. Speakers will examine the latest innovations in treatment and discuss their implications for clinical practice and patient outcomes. Special attention will be given to access challenges, and reimbursement models.

Chair

Alok Srivastava, MD, FRACP, FRCPA, FRCP
BOD medical member, World Federation of Hemophilia
Professor and Head, Haematology Research Unit, St. John’s Research Institute
Senior Consultant, Department of Clinical Haematology, St. John’s Medical College Hospital
Bengaluru, India

Current and emerging therapies for hemophilia

Cedric Hermans, Head, Hemophilia Centre, Cliniques universitaires Saint-Luc, Brussels, Belgium

Treatment landscape for VWD and other bleeding disorders

Nathan Connell, Chief of Medicine, Brigham and Women’s Faulkner Hospital, Boston, United States

Opportunities and challenges in accessing treatment – reimbursement models

Jamie O’Hara, Senior lecturer of health economics, University of Chester, Stretton, United Kingdom


10:45 – 11:00

BREAK


11:00 – 12:00

EDUCATIONAL SESSION

WHO Essential medicines list 2025 – Update and impact on bleeding disorders

This session will offer the latest updates on the WFH advocacy and submissions as part of the WHO Essential Medicines List (EML) 2025 review. Experts will also discuss the impact of the WHO EML on national procurement policies and health system planning.

Chair

Salome Mekhuzla, Director – Global Development, World Federation of Hemophilia, Montreal, Canada

The WHO Essential Medicines List

Lorenzo Moja, Team Lead, EML Secretariat, World Health Organization, Geneva, Switzerland

2025 update of the WHO EML for bleeding disorder therapies

Glenn Pierce, Vice-president Medical, World Federation of Hemophilia, La Jolla, United States

Case study: Use of EML to inform national procurement

Malick Anne, Head, Division of Non-Communicable Disease, Ministry of Health, Dakar, Senegal


12:00 – 12:30

BREAK


12:30 – 13:45

EDUCATIONAL SESSION

Collaborative strategies for increasing access to treatment in bleeding disorders

Learn how multi-stakeholder collaboration can drive sustainable access to care for people with bleeding disorders. Presentations will highlight the use of data to build compelling advocacy cases and strategies for navigating data gaps. A panel of experts will discuss the importance of inclusive approaches that address the needs of WGBD, individuals with VWD, and those with rare bleeding disorders.

Chair

Dawn Rotellini, Chief operating officer, National Bleeding Disorders Foundation, Gibsonia, United States

Leveraging partnerships for effective advocacy

Bradley Rayner, Head – Programmes, South African Haemophilia Foundation, Cape Town, South Africa

Data driven advocacy for sustainable access

Brian O’Mahony, Chief Executive, Irish Haemophilia Society, Dublin, Ireland

Panel discussion on advocating for increased access to treatment for bleeding disorders

Abira Maheen, Joint Secretary, Hemophilia Foundation Pakistan, Rawalpindi, Pakistan
Matthew Delaney, Government relations manager, National Bleeding Disorders Foundation, New York, United States
Natalie Philbert, National programs director, Canadian Hemophilia Society, Ontario, Canada
Tatiana Bathfield, Founding member and Secretary, Haemophilia Association of Mauritius, Quatre Bornes, Mauritius


13:45 – 14:00

Day 1 WRAP UP


09:00 – 10:00

PANEL DISCUSSION

Elevating bleeding disorders within national health policy frameworks

Explore how bleeding disorders can be prioritized within national health systems through effective policy integration. Government officials and NMO leaders will share real-world examples, discuss the role of national health plans, and outline strategies for engaging ministries of health and other key stakeholders. Emphasis will be placed on building sustainable frameworks that ensure long-term access to care and treatment.

Chair

Rana Saifi, Regional manager – Middle East, World Federation of Hemophilia, Montreal, Canada

Panelists

Alayo Sopekan, Deputy Director, Federal Ministry of Health, Abuja, Nigeria
Rahul UR, State Nodal Officer for Child Health & Rare Diseases, Government of Kerala, Kerala, India
Feng Xue, Chief Physician, Thrombosis and Hemostasis Center, Institute of Hematology and Blood Diseases Hospital, Tianjin, China
Jan Blatný, Haematologist and Paediatrician, University Hospital Brno, Masaryk University, and Institute for Postgraduate Education of Health-care Professionals, Brno and Prague, Czech Republic
Ekawat Suwantaroj, Vice President, Thai Hemophilia Patient Club, Bangkok, Thailand


10:00 – 11:00

LIGHTNING ROUND SESSION

Around the world in 60 minutes – Successes and lessons learned from WFH NMO advocacy initiatives

Experience a dynamic, fast-paced showcase of advocacy initiatives led by WFH National Member Organizations across diverse regions. Each presentation offers a concise case study highlighting diverse approaches to overcoming barriers in diagnosis, treatment access, and care delivery. Attendees will gain practical insights into what has worked, what challenges remain, and how the lessons learned can be adapted to different contexts.

Chair

Julia Rauscher, Co-chair, European Haemophilia Consortium VWD Committee, Austria
Masood Fareed Malik, President, Hemophilia Foundation Pakistan, Lahore, Pakistan

NMO advocacy initiatives


11:00 – 11:15

BREAK


11:15 – 12:15

WFH HIGHLIGHT SESSION

Advancing Health Equity: PACT Program

Take a closer look at the impact of the WFH Path to Access to Care and Treatment (PACT) Program, launched to strengthen outreach, diagnosis, and increase access to sustainable treatment and care for people with bleeding disorders globally. Learn about the PACT Advocacy Academy and hear directly from program graduates on the impact this course has had on advocacy work in their countries. The session underscores the importance of capacity-building and community leadership in driving systemic change.

Chair

Mathieu Jackson, Board of Directors lay member, World Federation of Hemophilia, Lausanne, Switzerland

Update on the PACT program outcomes and the PACT Advocacy Academy

Salome Mekhuzla, Director – Global development, World Federation of Hemophilia, Montreal, Canada

Sharing of experiences from PACT Advocacy Academy graduates

Aizat Aidarbekova, Volunteer, Kyrgyz Hemophilia Society, Kyrgyzstan
Minackshi Dhurmoo-Luchmun, Program Coordinator, Haemophilia Association of Mauritius, Quatre Bornes, Mauritius
Abu Sayeed Arif, General Secretary, Hemophilia Society of Bangladesh, Bangladesh


12:15 – 12:45

BREAK


12:45 – 13:30

EDUCATIONAL SESSION

Shared Decision Making: Transforming Clinical Practice Across Resource Settings

Discover the value of a shared decision-making (SDM) approach in empowering individuals with bleeding disorders to make shared and informed treatment decisions and learn about the WFH SDM Tool. Presenters will explore the application of SDM in both high-income and resource-limited settings, highlighting its role in improving patient satisfaction and outcomes. The session will also introduce tools and frameworks that support the integration of SDM into clinical workflows and advocacy efforts.

Chair

Donna Coffin, Director – Research and Data, World Federation of Hemophilia, Montreal, Canada

Implementing SDM in different resource settings

Emna Gouider, Vice-president NMO, World Federation of Hemophilia, Tunis, Tunisia
Pratima Chowdary, Consultant haematologist, Royal Free Hospital, London, United Kingdom

SDM from the perspective of PWBD

Juan Andrés Pereira de Souza, President, Uruguayan Hemophilia Association, Montevideo, Uruguay
Arnoud Plat, President, The Netherlands Haemophilia Society, The Netherlands


13:30 – 14:30

PANEL DISCUSSION

Co-Creating a Sustainable Future for the Bleeding Disorders Community

This session will conclude the GPAS program with a forward-looking dialogue on the future of care, advocacy, and innovation in the bleeding disorders space. Panelists will address persistent gaps in access, emerging treatment technologies, and the role of patient organizations.

Chair

Glenn Pierce, Vice-president Medical, World Federation of Hemophilia, La Jolla, United States

Panelists

Cesar Garrido, President, World Federation of Hemophilia, Caracas, Venezuela
Neil Bertelsen, Owner, Neil Bertelsen Consulting, Berlin, Germany
Mark Skinner, President and Chief Executive Officer, Institute for Policy Advancement Ltd, Washington, DC, United States
Emna Gouider, Vice-president NMO, World Federation of Hemophilia, Tunis, Tunisia
Maria Elisa Mancuso, Senior Hematology Consultant, Centre for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Milan, Italy


Interpretation available in English, Spanish, French, Arabic, Russian, German, Portuguese, Chinese (Mandarin), Hindi & Urdu

All times are listed in eastern daylight time (EDT)

Program is subject to change

INFORMACIÓN DE INSCRIPCIÓN

Vea las grabaciones de las sesiones en la plataforma del evento hasta el 10 de septiembre de 2025.

Para obtener más información sobre la inscripción escriba a [email protected].

La FMH puede ofrecer eventos como la GPAS de manera gratuita gracias al apoyo recibido de nuestros generosos donantes. Al hacer un donativo a la FMH estará apoyando iniciativas de cabildeo nacionales y mundiales, a fin de dar voz a todas las personas con trastornos de la coagulación. Su apoyo es vital—agradeceremos considere hacer un donativo hoy en give.wfh.org

Comité del Programa del GPAS y Ponentes

Conozca a los miembros del Comité de Programa del GPAS y Ponentes

Mostrar todo

Miembros del comité

Ponentes

Aizat Aidarbekova

Ponente

Kirguistán

Malick ANNE

Ponente

Senegal

Tatiana Bathfield

Miembro del comité

Islas Mauricio

Alain Baumann

Miembro del comité

Canadá

Neil Bertelsen

Ponente

Alemania

Emily Blanchette

Miembro del comité

Canada

Jan Blatný

Ponente

República Checa

Pratima Chowdary

Ponente

Reino Unido

Donna Coffin

Ponente

Canadá

Nathan Connell

Ponente

Estados Unidos

Matthew Delaney

Ponente

Estados Unidos

Minackshi Dhurmoo Luchmun

Ponente

Mauricio

César Garrido

Presidente

Venezuela

Emna Gouider

Miembro del comité

Túnez

Cedric Hermans

Ponente

Bélgica

Mathieu Jackson

Ponente

Suiza

Abira Maheen

Ponente

Pakistán

Masood Fareed Malik

Miembro del comité

Pakistán

Maria Elisa Mancuso

Ponente

Italia

Santosh Manivannan

Miembro del comité

India

Salome Mekhuzla

Miembro del comité

Canadá

Lorenzo Moja

Ponente

Suiza

Deusdedit Mubangizi

Ponente

Suiza

Jamie O'Hara

Ponente

Reino Unido

Brian O'Mahony

Ponente

Irlanda

David Page

Miembro del comité

Canadá

Juan Andrés Pereira de Souza

Ponente

Uruguay

Natalie Philbert

Ponente

Canadá

Glenn Pierce

Ponente

Estados Unidos

Arnoud Plat

Ponente

Países Bajos

Julia Rauscher

Miembro del comité

Austria

Bradley Rayner

Ponente

Sudáfrica

Dawn Rotellini

Miembro del comité

Estados Unidos

Rana Saifi

Miembro del comité

Canadá

Abu Sayeed Arif

Ponente

Bangladesh

Mark W. Skinner

Miembro del comité

Estados Unidos

Alayo Sopekan

Ponente

Nigeria

Alok Srivastava

Ponente

India

Ekawat Suwantaroj

Miembro del comité

Tailandia

Rahul UR

Ponente

India

Feng Xue

Ponente

China

RECURSOS RELEVANTES

Recursos relevantes

¿Le interesa ponerse al día sobre las sesiones de GPAS 2023? Vea las grabaciones de sesiones selectas en la Plataforma de aprendizaje electrónico de la FMH.

PREGUNTAS FRECUENTES

Q
¿Quién se beneficiará participando en la GPAS?
A
  • Líderes y defensores de ONM de la FMH
  • Profesionales de la salud
  • Gobiernos nacionales
  • Otras organizaciones que representan los intereses de personas con trastornos de la coagulación
  • Agencias gubernamentales regionales y mundiales (tales como la OMS, etc.) y organizaciones aliadas
  • Representantes de la industria
  • Investigadores, y cualquier persona con interés en el campo de los trastornos de la coagulación
Q
¿Habrá grabaciones disponibles después dele vento?
A

Todas las sesiones estarán disponibles a pedido durante 90 días, solamente en inglés. Puede tener acceso a ellas en esta misma plataforma del evento. Las grabaciones de las sesiones aparecerán 24 horas después de que se realicen; no estarán disponibles en ningún otro idioma.

Q
¿Habrá interpretación en vivo?
A

El evento contará con interpretación en vivo en inglés, español, francés, árabe, ruso, alemán, portugués, chino (mandarín), hindi y urdu.

Q
¿Cuándo recibiré la información para iniciar sesión a fin de tener acceso al evento virtual?
A

La información para iniciar sesión se enviará a todos los participantes inscritos el 4 de julio de 2025.

Si desea obtener más información escriba a [email protected].

NOTICIAS DE GPAS

Acompáñenos durante la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento

Inscríbase ahora para la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento

¡Tenemos el gusto de anunciar que ya están abiertas las inscripciones a la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento (GPAS por su sigla en inglés)! Este evento virtual de dos días de duración tendrá lugar del 10 al 11 de julio de 2025 y constituye una singular oportunidad para formar parte de la conversación en torno a estrategias a fin de preservar e impulsar la atención de los trastornos de la coagulación en el mundo actual en rápida evolución....

PATROCINADORES

La cuarta edición de la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento (GPAS por su sigla en inglés) recibe apoyo financiero de Hemophilia Alliance y de sus centros de tratamiento de hemofilia (CTH) miembros, en todo Estados Unidos.

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.